Nu-Med Plus, Inc.
Datakwaliteit: 83%
NUMD
OTC
Manufacturing
Measuring & Analyzing Instruments
€ 0,01
▲
€ 0,00
(9,24%)
Marktkapitalisatie: 1,09 M
Prijs
€ 0,01
Marktkapitalisatie
1,09 M
Dagbereik
€ 0,01 — € 0,01
52-Weeksbereik
€ 0,01 — € 0,10
Volume
14.200
Openen € 0,01
50D / 200D Gem.
€ 0,01
6,47% below
50D / 200D Gem.
€ 0,03
52,73% below
Quick Summary
Belangrijkste Punten
Negative free cash flow of -4.433,0
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
N/A
Current Ratio0,03
Interest Coverage-12,63
Waardering
PE (TTM)
-15,89
Onder sectorgemiddelde (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Koershistorie
Financiële Trends
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)
Sectorvergelijking
vs Manufacturing sector mediaan (1364 peers)| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -15,9 | -1,5 |
| P/B | — | 1,6 |
| ROE % | — | -53,4 |
| Net Margin % | — | -41,5 |
| Rev Growth 5Y % | — | 1,8 |
| D/E | — | 0,3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -68.345,0 |
| ROE | N/A | ROA | -862,02% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -4.433,0 |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,03 |
| Interest Coverage | -12,63 | Asset Turnover | N/A |
| Working Capital | -204.541 | Tangible Book Value | -204.541 |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -15,89 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -0,41% | ||
| Market Cap | 1,09 M | Enterprise Value | 1,09 M |
| Per Share | |||
| EPS (Diluted TTM) | 0,00 | Revenue / Share | N/A |
| FCF / Share | 0,00 | OCF / Share | 0,00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 6,49% |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | 0,0 |
| Net Income | -68.345,0 | -125.526,0 | -130.167,0 | -830.061,0 | -2,01 M |
| EPS (Diluted) | 0,00 | 0,00 | 0,00 | -0,01 | -0,04 |
| Gross Profit | — | — | — | — | — |
| Operating Income | -63.331,0 | -120.526,0 | -182.167,0 | -839.445,0 | -1,99 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | 2.267,0 | 2.267,0 | 9.365,0 | 11.794,0 |
| Interest Expense | 5.014,0 | -5.000,0 | 1.000,0 | 14.322,0 | 14.322,0 |
| Income Tax | — | — | — | — | 0,0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 9.373,0 | 13.456,0 | 79.545,0 | 22.163,0 | 557.135,0 |
| Total Liabilities | 224.469,0 | 160.207,0 | 142.570,0 | 154.521,0 | 89.432,0 |
| Shareholders' Equity | -215.096,0 | -146.751,0 | -63.025,0 | -132.358,0 | 467.703,0 |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | 2.373,0 | — | — | 188.506,0 | 188.506,0 |
| Current Assets | 9.373,0 | 13.456,0 | 79.545,0 | 11.675,0 | 537.523,0 |
| Current Liabilities | 224.469,0 | 160.207,0 | 142.570,0 | 154.521,0 | 80.048,0 |
{"event":"ticker_viewed","properties":{"ticker":"NUMD","listing_kind":"stock","pathname":"/stocks/numd","exchange":"OTC","country":"US"}}